BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26075562)

  • 1. Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
    Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
    Ann Am Thorac Soc; 2015 Jun; 12(6):960. PubMed ID: 26075562
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
    Burger CD
    Ann Am Thorac Soc; 2015 Jun; 12(6):959. PubMed ID: 26075561
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
    Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
    Ann Am Thorac Soc; 2015 Feb; 12(2):269-73. PubMed ID: 25590376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing perceptions in pulmonary hypertension.
    Gerges C; Lang IM
    Lancet Respir Med; 2014 Jan; 2(1):21-3. PubMed ID: 24461891
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary hypertension].
    Kovacs G; Olschewski H
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
    [No Abstract]   [Full Text] [Related]  

  • 6. Macitentan for the treatment of pulmonary arterial hypertension.
    DuBrock HM; Channick RN
    Expert Rev Respir Med; 2014 Aug; 8(4):393-9. PubMed ID: 24998329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension: a review in pharmacotherapy.
    Patel BB; Feng Y; Cheng-Lai A
    Cardiol Rev; 2015; 23(1):33-51. PubMed ID: 25275717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has the 6-min walk distance run its course?
    McLaughlin VV
    Chest; 2012 Dec; 142(6):1363-1365. PubMed ID: 23208324
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel medical therapies for pulmonary arterial hypertension.
    O'Connell C; O'Callaghan DS; Humbert M
    Clin Chest Med; 2013 Dec; 34(4):867-80. PubMed ID: 24267310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macitentan for the treatment of pulmonary arterial hypertension.
    Kholdani CA; Fares WH; Trow TK
    Vasc Health Risk Manag; 2014; 10():665-73. PubMed ID: 25473292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is new in the treatment of pulmonary artery hypertension?].
    Pulido Zamudio T
    Arch Cardiol Mex; 2003; 73 Suppl 1():S121-4. PubMed ID: 12966661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Targeted therapy of pulmonary arterial hypertension (PAH)].
    Klose H; Opitz C; Bremer H; Ewert R; Bonderman D; Rosenkranz S; Seeger W; Schmeißer A; Harbaum L; Buerke M; Ghofrani HA; Borst MM; Leuchte HH; Lange TJ; Behr J; Ulrich S; Lang I; Olschewski H; Gall H; Kabitz HJ; Kleber FX; Held M; Hoeper MM; Grünig E
    Dtsch Med Wochenschr; 2014 Dec; 139 Suppl 4():S142-50. PubMed ID: 25489684
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systemic sclerosis - an update].
    Bergmann C; Distler JH
    Dtsch Med Wochenschr; 2015 Apr; 140(7):504-7. PubMed ID: 25826034
    [No Abstract]   [Full Text] [Related]  

  • 14. [The current pharmacotherapy of pulmonary arterial hypertension].
    Betkier-Lipińska K; Ryczek R; Cwetsch A
    Pol Merkur Lekarski; 2015 Jan; 38(223):34-8. PubMed ID: 25763586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways in pulmonary arterial hypertension: the future is here.
    Sitbon O; Morrell N
    Eur Respir Rev; 2012 Dec; 21(126):321-7. PubMed ID: 23204120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on pharmacotherapy for pulmonary hypertension.
    Prior DL; Adams H; Williams TJ
    Med J Aust; 2016 Sep; 205(6):271-6. PubMed ID: 27627939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapies for pulmonary arterial hypertension.
    Pulido T; Zayas N; de Mendieta MA; Plascencia K; Escobar J
    Heart Fail Rev; 2016 May; 21(3):273-83. PubMed ID: 26791159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macitentan (Opsumit) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2014 Feb; 56(1436):15-6. PubMed ID: 24663031
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of oral treatments on clinical outcomes in pulmonary arterial hypertension: A systematic review and meta-analysis.
    Zhang HD; Zhang R; Jiang X; Sun K; Wu DC; Jing ZC
    Am Heart J; 2015 Jul; 170(1):96-103, 103.e1-14. PubMed ID: 26093869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on pulmonary arterial hypertension pharmacotherapy.
    Velayati A; Valerio MG; Shen M; Tariq S; Lanier GM; Aronow WS
    Postgrad Med; 2016 Jun; 128(5):460-73. PubMed ID: 27232660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.